Market Overview

Goldman Raises Target On PayPal To $49 Following Q3 Earnings

Share:
Goldman Raises Target On PayPal To $49 Following Q3 Earnings

Paypal Holdings Inc (NASDAQ: PYPL) reported its Q3 results, with the revenue coming in at $2.67 billion, marginally ahead of the consensus forecast.

Goldman Sachs’ Heath P. Terry maintains a Buy rating on the company, while raising the price target from $47 to $49.

Q3 Results

FX-neutral revenue grew 21 percent year-on-year, as compared to 19.5 percent in Q2, driven by FX-neutral TPV growth of 28 percent.

The adjusted operating income, however, came in at $490 million, below the consensus expectations, while adjusted operating margins stood at 18.4 percent, as compared to 19.9 percent for Q3:15.

Terry mentioned that the decline was driven by “mix shift to Braintree and higher-than-expected credit provisions.”

Related Link: PayPal's Results Were "OK, But High Visibility Strengthens Conviction"

Investor Concerns

“While investor focus remains on competitive uncertainties, near-term margin pressures from mix shift, and needed investment, we believe TPV growth from the growing ubiquity of the service and incremental engagement from new product offerings like One Touch will drive continued outperformance,” the analyst went on to say.

Mobile TPV growth remained flat sequentially at 56 percent year-on-year, while the take rate was 3.05 percent, below the Q2 levels.

Adjusted operating margins declined 150 bps year-on-year, driven primarily by a decline in transaction margins.

Transaction and loss expenses increased 29 percent year-on-year.

At last check, Paypal was up 8.18 percent at $43.37.

Full ratings data available on Benzinga Pro.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Latest Ratings for PYPL

DateFirmActionFromTo
Aug 2019UpgradesSellNeutral
Jul 2019DowngradesNeutralSell
Jul 2019MaintainsOutperform

View More Analyst Ratings for PYPL
View the Latest Analyst Ratings

Posted-In: Analyst Color Earnings Long Ideas News Price Target Reiteration Analyst Ratings Movers Best of Benzinga

 

Related Articles (PYPL)

View Comments and Join the Discussion!

Are The Drugs Working? Pharma Giants Eli Lilly And Merck To Update Investors On Cancer Treatments

EUR/USD Lower Ahead of Data